Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ISRCTN15215837) titled 'Real-world evaluation of the GALEAS™ Bladder biomarker for bladder cancer detection' on June 24.
Study Type: Observational
Study Design:
Cohort study
Primary Sponsor: Nonacus Limited
Condition:
Adults referred for bladder cancer investigation following the detection of either visible haematuria (VH) or non-visible haematuria (NVH).
Cancer
Intervention:
Design
This study is an observational real-world evaluation study conducted across seven UK NHS Urology Departments. All participants underwent standard diagnostic procedures for haematuria investigation, including flexible cystoscopy for direct bladder ...